Why the study?
What are the long-term outcomes and predictors of mortality in patients undergoing concomitant AVR and CABG for aortic stenosis?
What are the long-term outcomes and predictors of mortality in patients undergoing concomitant AVR and CABG for aortic stenosis?
Answers are grounded in this paper and cite their sources.
Concomitant AVR and CABG for aortic stenosis has acceptable long-term survival, with age, reduced GFR, and increased LV mass being significant predictors of mortality.
BACKGROUND: We evaluated the surgical results and predictors of long-term survival in patients who underwent coronary artery bypass grafting (CABG) at the time of an aortic valve replacement (AVR) due to aortic stenosis. MATERIALS AND METHODS: Between January 1990 and December 2009, 183 consecutive patients underwent CABG and concomitant aortic valve replacement for aortic stenosis. The mean follow-up period was 59.8±3.3 months and follow-up was possible in 98.3% of cases. Predictors of mortality were determined by Cox regression analysis. RESULTS: There were 5 (2.7%) in-hospital deaths. Follow-up of the in-hospital survivors documented late survival rates of 91.5%, 74.8%, and 59.6% at 1, 5, and 10 postoperative years, respectively. Age (p<0.001), a glomerular filtration rate (GFR) less than 60 mL/min (p=0.006), and left ventricular (LV) mass (p<0.001) were significant predictors of mortality in the multivariate analysis. CONCLUSION: The surgical results and long-term survival of aortic valve replacement with concomitant CABG in patients with aortic stenosis and coronary artery disease were acceptable. Age, a GFR less than 60 mL/min, and LV mass were significant predictors of mortality.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: